Article
Low Dose Radiation by Radiopharmaceutical Therapy Enhances GD2 <i>TRAC-</i> CAR T Cells Efficacy in Localized Neuroblastoma
2024-11-03
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> While chimeric antigen receptor (CAR) T cells have achieved significant success against hematological malignancies, efficacy against neuroblastoma has been limited. Virus-free CRISPR-edited GD2 TRAC- CAR T cells have been developed as a potential means of improving CAR T efficacy but are not curative. Radiopharmaceutical therapy (RPT) is a promising approach to enhance the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d3ad3557-07e4-5547-84ba-8bb5ee4fa9fa
- DOI
- 10.1101/2024.11.02.621668
